Early diagnosis technology – ONCO SCREENING

Objective

To provide efficient early diagnosis of oncological diseases.

ONCO SCREENING/

Stage:/

Clinical trial/

Technology of early preliminary treatment of the oncological diseases. ONCO SCREENING is a new approach to screening of the malignant new growths, engaging use at the first stage of a diagnostic study of the universal method screening preliminary treatment.

Complete the form below to get detailed business plan: /


ONCO SCREENING/

Stage:/

Clinical trial/

The method taken as a principle of technology is based on the detection in surveyed whey fibers or polypeptides with changed chemical, and-or physical properties which are synthesized by tumoral cages from the beginning of their origination.

Interacting with these fibers of special reagents and affecting on light response of certain power and spectrum leads to change of optical density of investigated whey in comparison with the control which is the whey of the same surveyed, but without reagents.

Response reading is carried out at the expense of whey scanning over the range a visible spectrum (360 – 600 nanometers). Thus, the effect of scanning of the control uses as a zero line. Spectrograms of oncological patients have the characteristic peaks of optical density corresponding to the anomalous fibers, reacted with reagents.

These pathological fibers can be different in different patients and at different swellings (this theme is the future design subject), however they, reacting with certain reagents come to light at scanning over the range a visible spectrum.

At healthy people these fibers miss, that allows to use the given method for early preliminary treatment of patients with oncological diseases, irrespective of origination place and a swelling morphological structure.

Complete the form below to get detailed business plan: /


ONCO SCREENING/

Stage:/

Clinical trial/

Technology develops of 3 basic components: (a) laboratory, (b) hardware and software room and (c) organizational. As a substance for probe serves a whey of person blood.

Laboratory unit engages special machining of surveyed whey by chemical and physical affecting (light).

Hardware and software unit engages the specialized spectrophotometer and the software. It is intended for obtaining of response effect, machining and storage of information, database forming.

An organizational unit is an integral part of technology and engages rational takeoff of contingents for survey realization, patients allocation to additional methods of preliminary treatment depending on testing effects, dynamic observation for surveyed throughout the long-term period. Medial time from a blood taking before obtaining of response effect makes 2.5 hours.

Complete the form below to get detailed business plan: /


ONCO SCREENING/

Stage:/

Clinical trial/

  • Efficiency of ONCO SCREENING is not lower than the results known markers of malignant growth
  • Method can be used to monitor oncological patients after treatment
  • Ability to monitor patients with any malignancy localization, including those without markers
  • High self-descriptiveness
  • Simplicity of fulfillment

Complete the form below to get detailed business plan: /